Search Results for "Depuy Asr Trial In California Latest News"

18:00 EDT 27th May 2015 | BioPortfolio

Matching Channels

California encephalitis

California

In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...

Matching News

DePuy ASR Lawsuit News: Bernstein Liebhard LLP Comments on California Court’s Recent Order Extending Dismissal Statute for Cases Transferred to Federal Proceeding

New York, New York (PRWEB) March 09, 2015 A California Court overseeing hundreds of DePuy ASR hip lawsuits ( http://www.consumerinjurylawyers.com/DePuy/ ) filed in the state has issued an Order ext...

DePuy gains exclusive rights to market Radlink's imaging system

A global sales deal has been struck between DePuy Synthes and Radlink to allow DePuy to exclusively market Radlink's Galileo  -More- 

DePuy Spine, Inc. - Medical Equipment - Deals and Alliances Profile

Summary DePuy Spine, Inc. (DePuy Spine) is a medical instrument manufacturer. The company manufactures and distributes spinal care products, surgical devices and instruments. Its products include ante...

News Headlines, PTV News: May 12, 2010

Today's forthcoming news stories: Merck & Co discontinues development of a follow-on biologic; Roche and Galapagos expand "smokers lung" drug R&D collaboration, and Living Cell Technologies discusses ...

Federal Court’s Selection of DePuy Pinnacle Hip Lawsuits as Potential Bellwether Candidates Prompts Comment From Bernstein Liebhard LLP

New York, New York (PRWEB) February 20, 2015 The federal litigation established in the U.S. District Court, Northern District of Texas for DePuy Pinnacle hip lawsuits ( http://www.consumerinjurylaw...

DePuy Synthes unveils new TFNA system

DePuy Synthes Companies of Johnson & Johnson has introduced new TFN-Advanced Proximal Femoral Nailing System (TFNA), developed to improve surgical treatment of hip fractures.

DePuy Synthes buys US-based Olive Medical

Orthopedic and neurological solutions provider DePuy Synthes Companies has acquired US-based Olive Medical, which provides high definition (HD) visualization systems for minimally invasive surgery (MI...

DePuy Synthes introduces new MatrixWAVE MMF System

The DePuy Synthes Companies of Johnson & Johnson has announced introduction of the new MatrixWAVE MMF System, designed for temporary stabilization of fractures of upper and lower jaw.

Matching PubMed Articles

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

Patients' preference to hear cancer diagnosis.

Bad news disclosure is one of the complex communication tasks of the physicians. Bad news is defined as:" any news that adversely and seriously affects an individual's view of his or her future". Rece...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement